Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double- blind comparison with phenytoin

Epilepsia

Volumn 40, Issue 5, 1999, Pages 601-607

  Steiner, T J ^a,h   Dellaportas, C I ^a,d   Findley, L J ^b   Gross, M ^c   Gibberd, F B ^d   Perkin, G D ^e   Park, D M ^f   Abbott, R ^g  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b HAROLD WOOD HOSPITAL   (United Kingdom)

^c EAST SURREY HOSPITAL   (United Kingdom)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e HILLINGDON HOSPITAL   (United Kingdom)

^f Southend Hospital   (United Kingdom)

^g LEICESTER ROYAL INFIRMARY   (United Kingdom)

^h IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Epilepsy; Lamotrigine; Monotherapy Phenytoin; Randomised controlled trial

Indexed keywords

LAMOTRIGINE; PHENYTOIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHENIA; ATAXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; GRAND MAL SEIZURE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE; TONIC CLONIC SEIZURE;

EID: 0032950428     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb05562.x     Document Type: Article

References (23)

1. Lamb RJ, Leach MJ, Miller AA, Wheatley PL. Anticonvulsant profile in mice of lamotrigine, a novel anticonvulsant. Br J Pharmacol 1985;85(suppl):235.
2. Millar AA, Whealley P, Sawyer DA, et al. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I Anticonvulsant profile in mice and rats. Epilepsia 1986;27:483-9.
3. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II Neurochemical studies on the mechanism of action. Epilepsia 1986;27:490-7.
4. Peck AW. Lamotrigine: historical background. Rev Contemp Pharmacother 1994;5:95-105.
5. Binnie CD, Debets RMC, Engelsman M, et al. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989;4:232-29.
6. Dren AT, Moore EL, and the US Lamictal Protocol 05 Clinical Trial Group. Placebo-controlled, dose-response evaluation of the efficacy and safety of lamotrigine (Lamictal) as add-on therapy in epileptic outpatients with partial seizures. Epilepsia 1991;32:20.
7. Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989;30:356-63.
8. Loiseau P, Yuen AWC, Duche B, et al. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res 1990;7:136-45.
9. Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: a multicentre, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994;35:113-21.
10. Sander JWAS, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC. A randomised, double-blind, placebo-controlled, add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990;6: 221-6.
11. Schapel GJ, Beran RG, Vajda FJE, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 1993;56:448-53.
12. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
13. Brodie MJ, Richens A, Yuen WC for UK Lamotrigine/ Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
14. Reunanen M, Dam M, Yuen AWC. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 1996;23:149-55.
15. Commission on Classification and Terminology of the International League Against Epilepsy. Proposals for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
16. Brown SW, Tomlinson LL. Anticonvulsant side-effects: a self report questionnaire for use in community surveys. Br J Clin Pract 1982;suppl 18:147-9.
17. Gillham R, Baker G, Thompson P, et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996;24:47-55.
18. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalised tonic-clonic seizures. N Engl J Med 1985; 313:145-51.
19. Young DS. Effects of drugs on clinical laboratory tests. Washington: AACC Press, 1990;3, 128-9.
20. Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997;17:109-12.
21. Richens A, Davidson DL, Cartlidge NE, Easter DJ, Adult EPITEG Collaborative Group. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. J Neurol Neurosurg Psychiatry 1994;57:682-7.
22. Kane K, Bryant-Comstock L, Gillham RA. Relationship between side effect and life satisfaction (SEALS) score, seizure occurrence and side effects to treatment in newly diagnosed patients with epilepsy. Epilepsia 1997;38(suppl 3):163.
23. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38:353-62.